Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide 40/5/25 mg is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Remedyrepack Inc.. The primary component is Olmesartan Medoxomil; Amlodipine; Hydrochlorothiazide.
| Product ID | 70518-2647_a68f9dab-08fd-3723-e053-2a95a90ab971 |
| NDC | 70518-2647 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide 40/5/25 mg |
| Generic Name | Olmesartan Medoxomil, Amlodipine And Hydrochlorothiazide Tablet 40/5/25 Mg |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 2020-03-24 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA203580 |
| Labeler Name | REMEDYREPACK INC. |
| Substance Name | OLMESARTAN MEDOXOMIL; AMLODIPINE; HYDROCHLOROTHIAZIDE |
| Active Ingredient Strength | 40 mg/1; mg/1; mg/1 |
| Pharm Classes | Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC],Calcium Channel Antagonists [MoA],Dihydropyridine Calcium Channel Blocker [EPC],Dihydropyridines [CS],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [CS] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |